CVS HEALTH CORPORATION Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid
CVS HEALTH CORPORATION (CVS) reported Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid of $59.81 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForLossesAndLossAdjustmentExpense · last filed 2026-08-05
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2026-06-30 was $30.61B, a 1.50% decline year-over-year.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2026-03-31 was $29.21B, a 0.50% increase year-over-year.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2025-12-31 was $33.67B, a 13.51% increase year-over-year.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2025-09-30 was $31.12B, a 9.16% increase year-over-year.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2025 was $124.93B, a 11.63% increase from fiscal 2024.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2024 was $111.91B, a 31.48% increase from fiscal 2023.
- CVS HEALTH CORPORATION liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2023 was $85.11B.
| Period end | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 3 month | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 6 month | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 9 month | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 12 month | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $30.61B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $59.81B 10-Q · filed 2026-08-05 | $93.49B derived: sum of 3 quarters · filed 2026-08-05 | $124.61B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $29.21B 10-Q · filed 2026-05-06 | $62.88B derived: sum of 2 quarters · filed 2026-05-06 | $94.00B derived: sum of 3 quarters · filed 2026-05-06 | $125.07B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $33.67B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $64.80B derived: sum of 2 quarters · filed 2026-02-10 | $95.87B derived: sum of 3 quarters · filed 2026-08-05 | $124.93B 10-K · filed 2026-02-10 | |
| 2025-09-30 | $31.12B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $62.19B derived: sum of 2 quarters · filed 2026-08-05 | $91.25B 10-Q · filed 2025-10-29 | $120.92B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $31.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $60.13B 10-Q · filed 2026-08-05 | $89.80B derived: sum of 3 quarters · filed 2026-08-05 | $118.31B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $29.06B 10-Q · filed 2026-05-06 | $58.73B derived: sum of 2 quarters · filed 2026-05-06 | $87.24B derived: sum of 3 quarters · filed 2026-05-06 | $115.56B derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $29.67B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $58.18B derived: sum of 2 quarters · filed 2026-02-10 | $86.50B derived: sum of 3 quarters · filed 2026-02-10 | $111.91B 10-K · filed 2026-02-10 | |
| 2024-09-30 | $28.51B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $56.83B derived: sum of 2 quarters · filed 2025-10-29 | $82.24B 10-Q · filed 2025-10-29 | $105.20B derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-06-30 | $28.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $53.73B 10-Q · filed 2025-07-31 | $76.69B derived: sum of 3 quarters · filed 2026-02-10 | $97.54B derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-03-31 | $25.41B 10-Q · filed 2025-05-01 | $48.37B derived: sum of 2 quarters · filed 2026-02-10 | $69.22B derived: sum of 3 quarters · filed 2026-02-10 | ||
| 2023-12-31 | $22.95B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $43.81B derived: sum of 2 quarters · filed 2026-02-10 | $85.11B 10-K · filed 2026-02-10 | ||
| 2023-09-30 | $20.86B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $62.16B 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $41.30B 10-Q · filed 2024-08-07 | ||||
| 2019-03-31 | $12.82B 10-Q · filed 2019-05-01 | ||||
| 2018-12-31 | $6.56B 8-K · filed 2019-08-08 | $6.72B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |